GH
Guardant Health IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$12.24B
P/E Ratio
—
EPS
$-3.45
Beta
1.65
52W High
$120.74
52W Low
$36.36
50-Day MA
$97.18
200-Day MA
$80.04
Dividend Yield
—
Profit Margin
-42.40%
Forward P/E
—
PEG Ratio
—
About Guardant Health Inc
Guardant Health, Inc., a precision oncology company, offers blood testing, data sets, and testing in the United States and internationally. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | $982.02M |
| Gross Profit (TTM) | $633.01M |
| EBITDA | $-396.56M |
| Operating Margin | -42.90% |
| Return on Equity | -4584.00% |
| Return on Assets | -15.60% |
| Revenue/Share (TTM) | $7.83 |
| Book Value | $-0.76 |
| Price-to-Book | 55.67 |
| Price-to-Sales (TTM) | 12.46 |
| EV/Revenue | 13.05 |
| EV/EBITDA | -5.40 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 39.40% |
| Shares Outstanding | $131.17M |
| Float | $126.11M |
| % Insiders | 4.04% |
| % Institutions | 101.27% |
Analyst Ratings
Consensus ($129.73 target)
5
Strong Buy16
Buy2
HoldData last updated: 4/8/2026